By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

The Immune Response Corporation, Inc. 

5935 Darwin Court

Carlsbad  California  92008  U.S.A.
Phone: 760-431-7080 Fax: 760-431-8636


SEARCH JOBS


Industry
Biotechnology






Company News
The Immune Response Corporation, Inc. (IMNR) Announces Rebranding to Reflect Expanded Focus on Treatment of Autoimmune Diseases 4/4/2007 1:37:40 PM
The Day In Review: Hollis-Eden Pharmaceuticals Inc. (HEPH) Loses Stockpile Contract For Neumune 3/8/2007 5:45:06 PM
The Immune Response Corporation, Inc. (IMNR) Injects First Patient in Trial of NeuroVax(TM) for Treatment of Multiple Sclerosis 3/8/2007 11:19:47 AM
The Immune Response Corporation, Inc. (IMNR) Extends Warrants Exercise Deadline 3/1/2007 11:07:38 AM
The Immune Response Corporation, Inc. (IMNR)'s Interim Phase II Data Suggest Both REMUNE And IR103 Stabilize CD4+ Cell Counts In Drug-Naive HIV Patients 2/15/2007 10:28:53 AM
The Immune Response Corporation, Inc. (IMNR) Announces Receipt Of Milestone Payment From NovaRx Corporation 1/5/2007 11:50:51 AM
The Immune Response Corporation, Inc. (IMNR) Announces New Trading Symbol As One-For-100 Reverse Stock Split Takes Effect 12/21/2006 2:34:38 PM
The Immune Response Corporation, Inc. (IMNR) To Present At New York Society of Security Analysts 10th Annual Biotech/Specialty Pharma Industry Conference 12/12/2006 2:13:35 PM
The Immune Response Corporation, Inc. (IMNR) Announces That Previously Approved One-for-100 Reverse Stock Split Will Take Effect On December 20, 2006 12/11/2006 11:56:44 AM
The Immune Response Corporation, Inc. (IMNR) To Present At The Wall Street Analyst Forum Biotechnology And Healthcare Conference 12/4/2006 3:11:02 PM
12345678910
//-->